HOME › DRUGS › ROSIGLITAZONE
ACTIVE SUBSTANCE / INN

ROSIGLITAZONE

Brand name(s): Avandia, Nyracta, Venvia
EMA LISTED
EXPIRED
WITHDRAWN
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Rosiglitazone
REGULATORS
EMA
SPONSORS / MAH
SmithKline Beecham Plc
TOTAL APPLICATIONS
3
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AvandiaSmithKline Beecham PlcExpired11/07/2000Diabetes Mellitus, Type 2
VenviaSmithKline Beecham PlcWithdrawn11/07/2000Diabetes Mellitus, Type 2
NyractaSmithKline Beecham PlcWithdrawn11/07/2000Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON ROSIGLITAZONE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →